Nassim Kamar
#127,521
Most Influential Person Now
Researcher
Nassim Kamar's AcademicInfluence.com Rankings
Nassim Kamarcomputer-science Degrees
Computer Science
#5430
World Rank
#5738
Historical Rank
Computational Linguistics
#756
World Rank
#769
Historical Rank
Machine Learning
#1444
World Rank
#1466
Historical Rank
Artificial Intelligence
#1675
World Rank
#1707
Historical Rank
Download Badge
Computer Science
Nassim Kamar's Degrees
- Masters Computer Science Stanford University
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Nassim Kamar Influential?
(Suggest an Edit or Addition)Nassim Kamar's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Hepatitis E virus and chronic hepatitis in organ-transplant recipients. (2008) (1163)
- Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients (2021) (588)
- Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. (2011) (553)
- Ribavirin for chronic hepatitis E virus infection in transplant recipients. (2014) (410)
- Hepatitis E Virus Antibodies in Blood Donors, France (2011) (350)
- EASL Clinical Practice Guidelines on hepatitis E virus infection. (2018) (329)
- Hepatitis E Virus Infection (2014) (304)
- Hepatitis E Virus and Neurologic Disorders (2011) (284)
- Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. (2010) (274)
- Hepatitis E virus infection (2017) (261)
- Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation. (2015) (259)
- Complement Genes Strongly Predict Recurrence and Graft Outcome in Adult Renal Transplant Recipients with Atypical Hemolytic and Uremic Syndrome (2013) (235)
- Hepatitis E Virus Strains in Rabbits and Evidence of a Closely Related Strain in Humans, France (2012) (225)
- Three‐Year Outcomes From BENEFIT‐EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys (2012) (223)
- Rituximab therapy for acute humoral rejection after kidney transplantation. (2007) (209)
- Influence of Immunosuppressive Therapy on the Natural History of Genotype 3 Hepatitis-E Virus Infection After Organ Transplantation (2010) (207)
- Hepatitis E Virus‐Related Cirrhosis in Kidney‐and Kidney–Pancreas‐Transplant Recipients (2008) (206)
- An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants (2020) (193)
- An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants (2020) (193)
- Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients (2010) (192)
- Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group (2017) (191)
- Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation. (2003) (189)
- Efficacy and Safety of Sofosbuvir‐Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney Transplantation (2016) (187)
- Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. (2010) (184)
- Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. (2005) (180)
- Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. (2010) (178)
- Hepatitis E Virus and the Kidney in Solid-Organ Transplant Patients (2012) (175)
- Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney‐Transplant Patients (2010) (171)
- Hepatitis E virus and neurological injury (2016) (171)
- Gonadal impact of target of rapamycin inhibitors (sirolimus and everolimus) in male patients: an overview (2007) (163)
- Complement Mutation‐Associated De Novo Thrombotic Microangiopathy Following Kidney Transplantation (2008) (159)
- Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study (2019) (158)
- Is COVID-19 infection more severe in kidney transplant recipients? (2020) (156)
- Belatacept-Based Regimens Versus a Cyclosporine A-Based Regimen in Kidney Transplant Recipients: 2-Year Results From the BENEFIT and BENEFIT-EXT Studies (2010) (155)
- Hepatitis E (2012) (153)
- Hepatitis E Virus Genotype 3 Diversity, France (2009) (152)
- Insertions and Duplications in the Polyproline Region of the Hepatitis E Virus (2020) (146)
- Hepatitis E Virus Infection without Reactivation in Solid-Organ Transplant Recipients, France (2011) (139)
- Long term outcomes of transplantation using kidneys from expanded criteria donors: prospective, population based cohort study (2015) (139)
- Rabbit Hepatitis E Virus Infections in Humans, France (2017) (132)
- Acute hepatitis E in south-west France over a 5-year period. (2009) (132)
- Hepatitis E virus reinfections in solid-organ-transplant recipients can evolve into chronic infections. (2014) (131)
- Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver Transplantation. (2015) (123)
- Leflunomide treatment for polyomavirus BK‐associated nephropathy after kidney transplantation (2007) (122)
- Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score. (2013) (118)
- How Should Hepatitis E Virus Infection Be Defined in Organ‐Transplant Recipients? (2013) (114)
- Natural History of Hepatitis C Virus‐Related Liver Fibrosis After Renal Transplantation (2005) (111)
- Simultaneous detection of gastrointestinal pathogens with a multiplex Luminex-based molecular assay in stool samples from diarrhoeic patients. (2013) (107)
- Diabetes mellitus after kidney transplantation: a French multicentre observational study. (2007) (106)
- Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients (2021) (103)
- Risk Factors of Pneumocystis Pneumonia in Solid Organ Recipients in the Era of the Common Use of Posttransplantation Prophylaxis (2015) (103)
- Correction of postkidney transplant anemia reduces progression of allograft nephropathy. (2012) (103)
- Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient. (2010) (100)
- Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients. (2013) (99)
- Safety and Immunogenicity of Anti–SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants (2021) (98)
- Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations--twice daily Prograf and once daily Advagraf. (2011) (98)
- Eculizumab Improves Posttransplant Thrombotic Microangiopathy Due to Antiphospholipid Syndrome Recurrence but Fails to Prevent Chronic Vascular Changes (2013) (96)
- Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin? (2011) (96)
- Hepatitis E Virus Quasispecies and the Outcome of Acute Hepatitis E in Solid-Organ Transplant Patients (2012) (94)
- Hepatitis E Virus Infection in Immunosuppressed Patients: Natural History and Therapy (2013) (92)
- Prevalence, Incidence and Risk Factors for Donor‐Specific Anti‐HLA Antibodies in Maintenance Liver Transplant Patients (2014) (91)
- Extrahepatic manifestations of hepatitis E virus (2016) (91)
- Population Pharmacokinetics and Bayesian Estimation of Tacrolimus Exposure in Renal Transplant Recipients on a New Once-Daily Formulation (2010) (91)
- Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated with Belatacept. (2021) (90)
- Analytical evaluation of HCV core antigen and interest for HCV screening in haemodialysis patients. (2010) (89)
- Occurrence of severe COVID-19 in vaccinated transplant patients (2021) (89)
- Carbonyl scavenger and antiatherogenic effects of hydrazine derivatives. (2008) (89)
- Long term results of liver transplantation for Wilson's disease: experience in France. (2014) (88)
- Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment. (2017) (87)
- Pneumocystis Pneumonia in Solid-Organ Transplant Recipients (2015) (85)
- Good Performance of Immunoglobulin M Assays in Diagnosing Genotype 3 Hepatitis E Virus Infections (2009) (85)
- Ribavirin pharmacokinetics in renal and liver transplant patients: evidence that it depends on renal function. (2004) (84)
- Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology. (2003) (83)
- Hepatitis E Virus Infects Neurons and Brains (2017) (82)
- Treatment of hepatitis C-virus-related glomerulonephritis. (2006) (82)
- Reduction of Extended‐Release Tacrolimus Dose in Low‐Immunological‐Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor‐Specific Antibodies: A Randomized Study (2017) (82)
- A useful scoring system for the prediction and management of delayed graft function following kidney transplantation from cadaveric donors. (2014) (82)
- A clinical scoring system highly predictive of long-term kidney graft survival. (2010) (82)
- High immunogenicity of a messenger RNA based vaccine against SARS-CoV-2 in chronic dialysis patients (2021) (82)
- High Dose Epoetin Beta in the First Weeks Following Renal Transplantation and Delayed Graft Function: Results of the Neo‐PDGF Study (2010) (81)
- Duodenal Villous Atrophy: A Cause of Chronic Diarrhea After Solid‐Organ Transplantation (2011) (80)
- mTOR inhibitor/proliferation signal inhibitors: entering or leaving the field? (2010) (79)
- Rituximab Therapy for De Novo Mixed Cryoglobulinemia in Renal Transplant Patients (2005) (79)
- Villous atrophy induced by mycophenolate mofetil in renal-transplant patients (2004) (79)
- Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomy. (2012) (79)
- Incidence of HCV infection in French hemodialysis units: A prospective study (2005) (79)
- IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT) (2020) (78)
- Hepatitis E Pathogenesis (2016) (77)
- Hepatitis E virus: chronic infection, extra-hepatic manifestations, and treatment. (2015) (76)
- Assessment of 4 Doses of SARS-CoV-2 Messenger RNA–Based Vaccine in Recipients of a Solid Organ Transplant (2021) (76)
- Hepatitis C virus-related kidney disease: an overview. (2008) (76)
- Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial. (2017) (74)
- Safety and efficacy of eculizumab in the prevention of antibody‐mediated rejection in living‐donor kidney transplant recipients requiring desensitization therapy: A randomized trial (2019) (73)
- Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant. (2006) (73)
- Chronic hepatitis E virus infection: successful virologic response to pegylated interferon-alpha therapy. (2010) (73)
- Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study. (2016) (73)
- Outcome and Treatment of Nocardiosis After Solid Organ Transplantation: New Insights From a European Study (2017) (72)
- Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens. (2019) (71)
- OSAKA Trial: A Randomized, Controlled Trial Comparing Tacrolimus QD and BD in Kidney Transplantation (2013) (69)
- Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions. (2004) (69)
- De novo donor‐specific anti‐HLA antibodies mediated rejection in liver‐transplant patients (2015) (68)
- Rituximab therapy for mixed cryoglobulinemia in seven renal transplant patients. (2006) (68)
- Sofosbuvir-based antiviral therapy in hepatitis C virus patients with severe renal failure (2016) (68)
- Entecavir Therapy for Adefovir-Resistant Hepatitis B Virus Infection in Kidney and Liver Allograft Recipients (2008) (68)
- Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized Trial (2017) (67)
- Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management. (2018) (67)
- Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey. (2011) (67)
- CYP3A5 Genotype Does Not Influence Everolimus In Vitro Metabolism and Clinical Pharmacokinetics in Renal Transplant Recipients (2011) (67)
- Hepatitis C virus and kidney disease. (2013) (66)
- Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports. (2007) (65)
- Seroprevalence in blood donors reveals widespread, multi-source exposure to hepatitis E virus, southern France, October 2011. (2015) (65)
- Impact of Early or Delayed Cyclosporine on Delayed Graft Function in Renal Transplant Recipients: A Randomized, Multicenter Study (2006) (64)
- Clinical phenotype and outcome of hepatitis E virus–associated neuralgic amyotrophy (2017) (64)
- Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease. (2013) (64)
- Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome. (2019) (64)
- Validation of Immunological Biomarkers for the Pharmacodynamic Monitoring of Immunosuppressive Drugs in Humans (2007) (64)
- Hepatitis E virus infection and acute non-traumatic neurological injury: A prospective multicentre study. (2017) (63)
- No evidence of occult hepatitis C virus (HCV) infection in serum of HCV antibody‐positive HCV RNA‐negative kidney‐transplant patients (2009) (63)
- Mutation in the Hepatitis E Virus Polymerase and Outcome of Ribavirin Therapy (2015) (63)
- Three-Dimensional Conformal Radiotherapy for Localized Prostate Cancer in Kidney Transplant Recipients (2004) (62)
- An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients. (2019) (62)
- Hepatitis E virus-induced severe myositis. (2012) (62)
- Acute renal failure following liver transplantation with induction therapy. (2006) (61)
- Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results. (2018) (61)
- Hepatitis E Virus: What Transplant Physicians Should Know (2012) (61)
- Liver histology in patients with sporadic acute hepatitis E: a study of 11 patients from South-West France (2007) (61)
- An Early Viral Response Predicts the Virological Response to Ribavirin in Hepatitis E Virus Organ Transplant Patients (2015) (60)
- Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney Transplantation (2016) (60)
- Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse. (2015) (60)
- Acute hepatitis and renal function impairment related to infection by hepatitis E virus in a renal allograft recipient. (2005) (59)
- Chronic hepatitis e virus infection and treatment. (2013) (59)
- Definitive Clearance of a Chronic Hepatitis E Virus Infection With Ribavirin Treatment (2011) (58)
- Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study. (2019) (57)
- Treatment of autochthonous acute hepatitis E with short‐term ribavirin: a multicenter retrospective study (2016) (56)
- Negative Impact of One-Year Anemia on Long-Term Patient and Graft Survival in Kidney Transplant Patients Receiving Calcineurin Inhibitors and Mycophenolate Mofetil (2008) (56)
- Influence of Polyproline Region and Macro Domain Genetic Heterogeneity on HEV Persistence in Immunocompromised Patients (2013) (54)
- Renal Transplantation in Patients With AA Amyloidosis Nephropathy: Results From a French Multicenter Study (2011) (54)
- Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. (2012) (54)
- GFR estimation using standardized cystatin C in kidney transplant recipients. (2013) (54)
- Characterization of the Polyproline Region of the Hepatitis E Virus in Immunocompromised Patients (2014) (52)
- Clinical Manifestations, Pathogenesis and Treatment of Hepatitis E Virus Infections (2020) (52)
- Hepatitis C and renal disease: epidemiology, diagnosis, pathogenesis and therapy. (2012) (52)
- Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E (2015) (51)
- Dynamic Prognostic Score to Predict Kidney Allograft Survival in Patients with Antibody-Mediated Rejection. (2017) (51)
- Performance of Two Commercial Assays for Detecting Hepatitis E Virus RNA in Acute or Chronic Infections (2013) (51)
- RIG‐I is a key antiviral interferon‐stimulated gene against hepatitis E virus regardless of interferon production (2017) (51)
- Hepatitis E virus seroprevalence in three hyperendemic areas: Nepal, Bangladesh and southwest France. (2015) (49)
- High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation (2018) (48)
- Impact of Early Blood Transfusion After Kidney Transplantation on the Incidence of Donor‐Specific Anti‐HLA Antibodies (2016) (48)
- Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID‐19 (2020) (48)
- Sofosbuvir and Daclatasvir Anti-Viral Therapy Fails to Clear HEV Viremia and Restore Reactive T Cells in a HEV/HCV Co-Infected Liver Transplant Recipient. (2017) (47)
- Successful treatment of hepatitis E virus‐associated cryoglobulinemic membranoproliferative glomerulonephritis with ribavirin (2015) (47)
- Improvement in renal function in kidney transplant recipients switched from cyclosporine or tacrolimus to belatacept: 2‐year results from the long‐term extension of a phase II study (2012) (46)
- Hepatitis E Virus-Induced Cryoglobulinemic Glomerulonephritis in a Nonimmunocompromised Person. (2016) (46)
- Questionnaire-based evaluation of gastrointestinal disorders in de novo renal-transplant patients receiving either mycophenolate mofetil or enteric-coated mycophenolate sodium. (2005) (46)
- Hepatitis E in developed countries: current status and future perspectives. (2014) (46)
- Ribavirin for chronic hepatitis E virus infection. (2014) (46)
- Hepatitis E virus replication in human intestinal cells (2019) (46)
- Predictive Factors for Posttransplant Diabetes Mellitus Within One-Year of Liver Transplantation (2008) (46)
- Incidence of donor‐specific antibodies in kidney transplant patients following conversion to an everolimus‐based calcineurin inhibitor‐free regimen (2013) (45)
- Assessing Renal Function With Daclizumab Induction and Delayed Tacrolimus Introduction in Liver Transplant Recipients (2010) (45)
- Donor-specific antibodies and liver transplantation. (2016) (45)
- Early plasmapheresis and rituximab for acute humoral rejection after ABO-compatible liver transplantation. (2009) (45)
- Maribavir use in practice for cytomegalovirus infection in French transplantation centers. (2013) (45)
- Erectile dysfunction in end-stage liver disease men. (2009) (44)
- Outcomes of patients with Goodpasture syndrome: A nationwide cohort-based study from the French Society of Hemapheresis. (2016) (44)
- Renal transplantation in patients with sarcoidosis: a French multicenter study. (2010) (43)
- Tenofovir Therapy in Hepatitis B Virus-Positive Solid-Organ Transplant Recipients (2011) (43)
- Anti-Human Leukocyte Antigen Immunization After Early Allograft Nephrectomy (2012) (43)
- Prospective evaluation of BK virus DNAemia in renal transplant patients and their transplant outcome. (2007) (42)
- Acute hepatitis E in French patients and neurological manifestations. (2018) (42)
- Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients (2009) (42)
- CNI withdrawal for post‐transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality (2014) (41)
- Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies (2015) (41)
- Conversion to Belatacept in Maintenance Kidney Transplant Patients: A Retrospective Multicenter European Study (2018) (41)
- Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantation (2013) (41)
- Predictive Factors of Anemia within the First Year Post Renal Transplant (2005) (41)
- Performance of an antigen assay for diagnosing acute hepatitis E virus genotype 3 infection. (2016) (41)
- Alpha-interferon therapy for chronic hepatitis C may induce acute allograft rejection in kidney transplant patients with failed allografts. (2007) (40)
- Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients (2018) (40)
- Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation (2012) (39)
- HLA Class I Antibodies Provoke Graft Arteriosclerosis in Human Arteries Transplanted into SCID/Beige Mice (2009) (39)
- A Key Role for Matrix Metalloproteinases and Neutral Sphingomyelinase-2 in Transplant Vasculopathy Triggered by Anti-HLA Antibody (2011) (39)
- Disseminated Herpes Simplex Type-2 (HSV-2) Infection After Solid-Organ Transplantation (2008) (38)
- Nitric oxide and carbon monoxide lung transfer in patients with advanced liver cirrhosis. (2009) (38)
- Development and Validation of a Modified Full Age Spectrum Creatinine-Based Equation to Estimate Glomerular Filtration Rate (2020) (37)
- Falsely elevated whole‐blood tacrolimus concentrations in a kidney‐transplant patient: potential hazards (2010) (37)
- Predictive Factors for Chronic Renal Failure One Year after Orthotopic Liver Transplantation (2006) (36)
- Hepatitis E virus infections in Europe. (2019) (35)
- Amantadine therapy in renal transplant patients with hepatitis C virus infection. (2004) (35)
- Transfusion-Transmitted Hepatitis E Virus Infection in France. (2019) (35)
- Sofosbuvir‐based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation (2016) (35)
- Characteristics of Thoracic Malignancies That Occur After Solid-Organ Transplantation (2010) (34)
- Characterization of the Specificity, Functionality, and Durability of Host T‐Cell Responses Against the Full‐Length Hepatitis E Virus (2016) (34)
- Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): a pragmatic, multicentre, randomised controlled trial. (2020) (34)
- Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppression. (2019) (33)
- Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic Hepatitis (2016) (33)
- Paracrine inhibition of GM-CSF signaling by human cytomegalovirus in monocytes differentiating to dendritic cells. (2011) (33)
- Acute and Persistent Hepatitis E Virus Genotype 3 and 4 Infection: Clinical Features, Pathogenesis, and Treatment. (2019) (32)
- Effect of CYP3A4*22, POR*28, and PPARA rs4253728 on sirolimus in vitro metabolism and trough concentrations in kidney transplant recipients. (2013) (32)
- Reversible posterior leukoencephalopathy syndrome in hepatitis C virus-positive long-term hemodialysis patients. (2001) (32)
- Temporal evolution of the distribution of hepatitis E virus genotypes in Southwestern France. (2015) (31)
- Diversity of hepatitis E virus genotype 3 (2018) (31)
- Incidence of JC‐Virus Replication After Rituximab Therapy in Solid‐Organ Transplant Patients (2008) (30)
- Clinical and genetic heterogeneity in familial steroid-sensitive nephrotic syndrome (2018) (30)
- Association of sirolimus adverse effects with m-TOR, p70S6K or Raptor polymorphisms in kidney transplant recipients (2012) (30)
- Treatment of hepatitis E virus (2016) (30)
- Kidney transplantation in patients with systemic sclerosis: a nationwide multicentre study (2017) (30)
- Predictive factors for cytomegalovirus reactivation in cytomegalovirus‐seropositive kidney‐transplant patients (2008) (29)
- A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders. (2017) (29)
- IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome (2020) (29)
- IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome (2020) (29)
- Diagnosis and management of asymptomatic bacteriuria in kidney transplant recipients: a survey of current practice in Europe (2018) (29)
- Early Corticosteroid Avoidance in Kidney Transplant Recipients Receiving ATG‐F Induction: 5‐Year Actual Results of a Prospective and Randomized Study (2014) (29)
- Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney‐transplant patients with chronic viral hepatitis (2009) (28)
- Disparity of basal and therapeutically activated interferon signalling in constraining hepatitis E virus infection (2016) (28)
- Acute rejection after anti–SARS-CoV-2 mRNA vaccination in a patient who underwent a kidney transplant (2021) (28)
- Pregnancy after kidney transplantation: outcome and anti-human leucocyte antigen alloimmunization risk. (2014) (28)
- Expanding the criteria of renal kidneys for transplantation: use of donors with acute renal failure. (2010) (28)
- Pharmacodynamic effects of cinacalcet after kidney transplantation: once- versus twice-daily dose. (2008) (28)
- Anti-SARS-CoV-2 Monoclonal Antibodies in Solid-organ Transplant Patients (2021) (28)
- Evolution and Determinants of Health-Related Quality-of-Life in Kidney Transplant Patients Over the First 3 Years After Transplantation (2016) (27)
- Pharmacodynamic evaluation of the first dose of mycophenolate mofetil before kidney transplantation. (2009) (27)
- Treatment of symptomatic transplant glomerulopathy with rituximab (2009) (27)
- Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C (2005) (26)
- G15 : The association of sofosbuvir and daclatasvir for treating severe recurrence of HCV infection after liver transplantation: Results from a large french prospective multicentric ANRS CO23 CUPILT cohort (2015) (26)
- Effectiveness of Immune Checkpoint Inhibitors in Transplant Recipients with Progressive Multifocal Leukoencephalopathy (2019) (26)
- Impact of molecular adsorbent recirculating system on renal recovery in type‐1 hepatorenal syndrome patients with chronic liver failure (2013) (26)
- Tabebuia avellanedae extracts inhibit IL-2-independent T-lymphocyte activation and proliferation. (2008) (25)
- Impact of post‐transplant anemia on patient and graft survival rates after kidney transplantation: a meta‐analysis (2012) (25)
- Indications for and barriers to preemptive kidney transplantation: a review. (2010) (25)
- Hepatitis E virus genotype 3 and capsid protein in the blood and urine of immunocompromised patients. (2019) (25)
- Early Steroid Withdrawal and Optimization of Mycophenolic Acid Exposure in Kidney Transplant Recipients Receiving Mycophenolate Mofetil (2011) (25)
- Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment (2022) (25)
- Hepatitis E Virus Infection in Solid Organ Transplant Recipients, France (2017) (25)
- Impact of estimation versus direct measurement of predonation glomerular filtration rate on the eligibility of potential living kidney donors. (2019) (25)
- Hypercalciuria induced by a high dose of cinacalcet in a renal-transplant recipient. (2007) (25)
- Influence of treatment with neutralizing monoclonal antibodies on the SARS-CoV-2 nasopharyngeal load and quasispecies (2021) (25)
- The age-calibrated measured glomerular filtration rate improves living kidney donation selection process. (2018) (24)
- Nepali earthquakes and the risk of an epidemic of hepatitis E (2015) (24)
- Renal side effects of adefovir in hepatitis B virus-(HBV) positive kidney allograft recipients. (2009) (24)
- Transmission of metallo-β-lactamase-producing Pseudomonas aeruginosa in a nephrology-transplant intensive care unit with potential link to the environment. (2016) (24)
- JC virus DNA in the peripheral blood of renal transplant patients: A 1‐year prospective follow‐up in France (2011) (24)
- Prospective monitoring of cytomegalovirus, Epstein-Barr virus, BK virus, and JC virus infections on belatacept therapy after a kidney transplant. (2014) (24)
- Monitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patients. (2019) (23)
- New-onset diabetes and nephropathy after renal transplantation. (2011) (23)
- Quantification of HEV RNA by Droplet Digital PCR (2016) (23)
- Heparin-Free Prolonged Intermittent Hemodialysis Using Calcium-Free Citrate Dialysate in Critically Ill Patients (2017) (23)
- Trajectories of glomerular filtration rate and progression to end stage kidney disease after kidney transplantation. (2020) (23)
- Successful treatment of fibrosing cholestatic hepatitis with pegylated interferon, ribavirin and sofosbuvir after a combined kidney–liver transplantation (2015) (22)
- Adherence profiles in kidney transplant patients: Causes and consequences. (2019) (22)
- Transonic, thermodilution, or ionic dialysance to manage vascular access: Which method is best? (2014) (22)
- Do anti‐IL‐6R blockers have a beneficial effect in the treatment of antibody‐mediated rejection resistant to standard therapy after kidney transplantation? (2020) (22)
- Propensity score–based comparison of the graft failure risk between kidney transplant recipients of standard and expanded criteria donor grafts: Toward increasing the pool of marginal donors (2018) (22)
- Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients (2017) (22)
- Rituximab for humoral rejection after kidney transplantation: an update. (2009) (22)
- Amanita phalloides poisoning-induced end-stage renal failure. (2009) (22)
- Anti-SARS-CoV-2 spike protein and neutralizing antibodies at 1 and 3 months after three doses of SARS-CoV-2 vaccine in a large cohort of solid organ transplant patients (2022) (22)
- Early Switch From Tacrolimus to Everolimus After Liver Transplantation: Outcomes at 2 Years (2019) (22)
- Conventional and innate lymphocytes response at the acute phase of HEV infection in transplanted patients. (2016) (22)
- Development and Evaluation of a Simulation Procedure to Take Into Account Various Assays for the Bayesian Dose Adjustment of Tacrolimus (2011) (22)
- Effects of long-term lamivudine therapy in renal-transplant patients. (2004) (22)
- Liberal selection criteria for liver transplantation for hepatocellular carcinoma (2009) (22)
- Unusual presentation of primary toxoplasmosis infection in a kidney-transplant patient complicated by an acute left-ventricular failure (2008) (22)
- No Reactivation of Hepatitis E Virus After Kidney Retransplantation (2012) (21)
- Robotic-assisted kidney transplantation in obese recipients compared to non-obese recipients: the European experience (2020) (21)
- Pilot conversion trial from mycophenolic acid to everolimus in ABO‐incompatible kidney‐transplant recipients with BK viruria and/or viremia (2016) (21)
- Early Administration of Anti–SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients (2022) (21)
- A multicenter, randomized trial of increased mycophenolic acid dose using enteric-coated mycophenolate sodium with reduced tacrolimus exposure in maintenance kidney transplant recipients. (2012) (21)
- Acute rejection after anti-SARS-CoV-2 mRNA vaccination in a kidney-transplant patient (2021) (20)
- Hepatitis E virus–associated cryoglobulinemia in solid‐organ–transplant recipients (2018) (20)
- Poor Long-Term Outcome in Second Kidney Transplantation: A Delayed Event (2012) (20)
- Tocilizumab for Hemophagocytic Syndrome in a Kidney Transplant Recipient With COVID-19 (2020) (20)
- Hepatitis E virus infection (2013) (20)
- Preemptive second kidney transplantation is associated with better graft survival compared with non‐preemptive second transplantation: a multicenter French 2000–2014 cohort study (2018) (20)
- Cytokines correlate with age in healthy volunteers, dialysis patients and kidney-transplant patients. (2009) (20)
- Perihepatitis and perinephric abscess due to Mycoplasma hominis in a kidney transplant patient. (2007) (20)
- Pharmacodynamic monitoring of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable kidney-allograft recipients. (2008) (19)
- Biological agents in kidney transplantation: belatacept is entering the field (2010) (19)
- Aspergillus fumigatus-related spondylodiscitis in a heart transplant patient successfully treated with voriconazole. (2007) (19)
- Long-term evolution of lymphocytes subsets after induction therapy based on continuous versus discontinuous administration of anti-thymocyte globulins in renal-transplant patients. (2005) (19)
- Induction therapy with either anti‐CD25 monoclonal antibodies or rabbit antithymocyte globulins in liver transplantation for hepatitis C (2005) (19)
- Conversion from Calcineurin Inhibitor– to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial (2021) (19)
- Pre‐emptive intravenous ganciclovir versus valganciclovir prophylaxis for de novo cytomegalovirus‐seropositive kidney‐transplant recipients (2010) (19)
- Reconstitution of immunodeficient SCID/beige mice with human cells: applications in preclinical studies. (2008) (19)
- Does chronic hepatitis E virus infection exist in immunocompetent patients? (2014) (19)
- Inhibition of T-cell activation and proliferation by mycophenolic acid in patients awaiting liver transplantation: PK/PD relationships. (2011) (19)
- Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study (2018) (19)
- Predictive factors of postrenal transplant anemia. (2005) (18)
- Classification of the Zoonotic Hepatitis E Virus Genotype 3 Into Distinct Subgenotypes (2021) (18)
- Evaluation of the efficacy and safety of a slow conversion from calcineurin inhibitor‐ to sirolimus‐based therapies in maintenance renal‐transplant patients presenting with moderate renal insufficiency (2007) (18)
- Screening, diagnosis and risks associated with Hepatitis E virus infection (2019) (18)
- Performance of a new rapid test for detecting anti-hepatitis E virus immunoglobulin M in immunocompetent and immunocompromised patients. (2015) (18)
- Resection of a Transplantable Single-Nodule Hepatocellular Carcinoma in Child-Pugh Class A Cirrhosis: Factors Affecting Survival and Recurrence (2011) (18)
- [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure]. (2002) (18)
- [Acute hepatitis E infection associated with Guillain-Barré syndrome in an immunocompetent patient]. (2014) (17)
- HEV and transfusion-recipient risk. (2017) (17)
- Erectile Dysfunction in Liver Transplant Patients (2008) (17)
- Schistosomiasis and Strongyloidiasis Recommendations for Solid-Organ Transplant Recipients and Donors. (2018) (17)
- Corticosteroid avoidance in adult kidney transplant recipients under rabbit anti‐T‐lymphocyte globulin, mycophenolate mofetil and delayed cyclosporine microemulsion introduction (2010) (17)
- Belatacept in recurrent focal segmental glomerulosclerosis after kidney transplantation (2015) (17)
- Pharmacokinetic Therapeutic Drug Monitoring of Advagraf in More Than 500 Adult Renal Transplant Patients, Using an Expert System Online (2018) (17)
- Villous atrophy induced by mycophenolate mofetil in renal‐transplant patients (2004) (17)
- Sofosbuvir-Based Regimens in HIV/HCV Coinfected Patients After Liver Transplantation: Results From the ANRS CO23 CUPILT Study (2018) (17)
- Impact of very early high doses of recombinant erythropoietin on anemia and allograft function in de novo kidney‐transplant patients (2010) (16)
- Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective. (2018) (16)
- Influence of Anemia on Patient and Graft Survival After Renal Transplantation: Results From the French DIVAT Cohort (2014) (16)
- Multidrug resistance-associated protein 4 (MRP4) controls ganciclovir intracellular accumulation and contributes to ganciclovir-induced neutropenia in renal transplant patients. (2016) (16)
- Hepatitis E virus. (2013) (16)
- Interference of therapeutic antibodies used in desensitization protocols on lymphocytotoxicity crossmatch results. (2015) (16)
- An alternative approach to estimate age‐related mortality of kidney transplant recipients compared to the general population: results in favor of old‐to‐old transplantations (2014) (16)
- Relapse of membranous glomerulopathy after kidney transplantation: sustained remittance induced by rituximab. (2008) (16)
- Lack of evidence for ribavirin monotherapy efficacy on liver fibrosis in hepatitis C virus positive renal transplant patients. (2005) (16)
- A candidate gene approach of the calcineurin pathway to identify variants associated with clinical outcomes in renal transplantation. (2016) (16)
- Reassessment of the clinical impact of preformed donor‐specific anti‐HLA‐Cw antibodies in kidney transplantation (2019) (15)
- Hepatitis E in Transplantation (2016) (15)
- Disseminated Ochroconis gallopava infection in a heart transplant patient (2013) (15)
- Allelic and Epitopic Characterization of Intra–Kidney Allograft Anti‐HLA Antibodies at Allograft Nephrectomy (2017) (15)
- Alternative complement pathway hemolytic assays reveal incomplete complement blockade in patients treated with eculizumab. (2017) (15)
- Assessment of glomerular and tubular functions in renal transplant patients receiving cyclosporine A in combination with either sirolimus or everolimus. (2005) (15)
- Dynamic predictions of long-term kidney graft failure: an information tool promoting patient-centred care. (2019) (15)
- Treatment of hepatitis C virus infection after kidney transplantation. (2012) (15)
- Twenty‐four hour kinetics of hepatitis C virus and antiviral effect of alpha‐interferon (2006) (15)
- Association of mGFR of the Remaining Kidney Divided by Its Volume before Donation with Functional Gain in mGFR among Living Kidney Donors. (2016) (15)
- Long-Term Kidney Transplant Outcomes: Role of Prolonged-Release Tacrolimus. (2019) (15)
- Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence after liver transplantation - The CO23 ANRS CUPILT study. (2016) (15)
- Sulfadiazine-related obstructive urinary tract lithiasis: an unusual cause of acute renal failure after kidney transplantation. (2005) (15)
- A third renal transplantation: is it relevant and is it worth it? (2005) (15)
- Occult hepatitis C virus infection in hemodialysis patients: examining the evidence. (2009) (14)
- Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients (2016) (14)
- Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial (2021) (14)
- Influence of Rituximab Therapy on Hepatitis C Virus RNA Concentration in Kidney‐Transplant Patients (2007) (14)
- Hepatitis C virus infection in nephrology patients. (2013) (14)
- Prophylaxis versus pre‐emptive treatment for prevention of cytomegalovirus infection in CMV‐seropositive orthotopic liver‐transplant recipients (2015) (14)
- Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline (2019) (14)
- European survey on the management of tuberculosis in solid‐organ transplant recipients and candidates (2013) (14)
- BK virus-related hemophagocytic syndrome in a renal transplant patient. (2007) (14)
- Does HEV‐3 subtype play a role in the severity of acute hepatitis E? (2019) (14)
- Dynamic prediction of renal survival among deeply phenotyped kidney transplant recipients using artificial intelligence: an observational, international, multicohort study. (2021) (14)
- Impact of Preoperative α-Fetoprotein Level on Disease-Free Survival After Liver Transplantation for Hepatocellular Carcinoma (2012) (14)
- New onset diabetes mellitus incidence and risk factors in kidney transplantation: results of the observational cross-sectional study diapason. (2006) (14)
- Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab (2022) (14)
- Transfusion‐acquired hepatitis E infection misdiagnosed as severe critical illness polyneuromyopathy in a heart transplant patient (2017) (14)
- Mortality Prediction after the First Year of Kidney Transplantation: An Observational Study on Two European Cohorts (2016) (14)
- Treatment of large plasma volumes using specific immunoadsorption to desensitize ABO-incompatible kidney-transplant candidates (2016) (14)
- Successful Transplantation in ABO‐ and HLA‐Incompatible Living Kidney Transplant Patients: A Report on 12 Cases (2016) (13)
- Prevalence of cryoglobulinemia and autoimmunity markers in renal-transplant patients. (2008) (13)
- Successful retransplantation of a kidney allograft affected by thrombotic microangiopathy into a second transplant recipient. (2008) (13)
- Aminothiols and allantoin in chronic dialysis patients: effects of hemodialysis sessions. (2010) (13)
- Tamoxifen therapy in kidney-transplant patients presenting with severe encapsulating peritoneal sclerosis after treatment for acute humoral rejection. (2009) (13)
- Identification of predictive markers and outcomes of late-onset Pneumocystis jirovecii pneumonia in kidney transplant recipients. (2020) (13)
- Ciclosporin Population Pharmacokinetics and Bayesian Estimation in Thoracic Transplant Recipients (2013) (13)
- Efficacy and safety of induction therapy with rabbit antithymocyte globulins in liver transplantation for hepatitis C. (2004) (13)
- Linezolid-induced interstitial nephritis in a kidney-transplant patient. (2007) (13)
- Immunoadsorption and Hemodialysis as a Tandem Procedure: A Single-Center Experience of More than 60 Procedures (2015) (13)
- An extension of the RITUX‐ERAH study, multicenter randomized clinical trial comparing rituximab to placebo in acute antibody‐mediated rejection after renal transplantation (2020) (13)
- Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation (2018) (13)
- Kidney histology and function in liver transplant patients. (2011) (13)
- Chronic hepatitis E: advancing research and patient care. (2022) (13)
- Ureteral stenosis as the sole manifestation of Wegener's granulomatosis. (2003) (13)
- Impact of rituximab therapy on response to tetanus toxoid vaccination in kidney-transplant patients. (2010) (13)
- Linezolid-Related Pancytopenia in Organ-Transplant Patients: Report of Two Cases (2007) (13)
- Alveolar and blood T lymphocyte profiles in Pneumocystis jirovecii-positive patients: effects of HIV status. (2011) (12)
- Performance of creatinine‐based equations to estimate glomerular filtration rate with a methodology adapted to the context of drug dosage adjustment (2021) (12)
- Pegylated Interferon-a for Treating Chronic Hepatitis E Virus Infection after Liver Transplantation (2010) (12)
- Mathematical modeling of hepatitis C virus transmission in hemodialysis. (2009) (12)
- Steroid avoidance with early intensified dosing of enteric-coated mycophenolate sodium: a randomized multicentre trial in kidney transplant recipients. (2012) (12)
- Hepatitis E virus‐specific T‐cell response after transplantation (2012) (12)
- No Clear Evidence for an Effect of Sofosbuvir Against Hepatitis E Virus in Organ Transplant Patients (2019) (12)
- Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation. (2019) (12)
- Hematologic adverse effects of 2 different polyclonal antilymphocyte preparations in de novo kidney transplant patients. (2010) (12)
- Does cyclosporine have a beneficial effect on the course of chronic hepatitis C infection after renal transplantation? (2006) (12)
- Predictive Factors for Humoral Response After 2-dose SARS-CoV-2 Vaccine in Solid Organ Transplant Patients (2021) (12)
- Improved Fetal Hemoglobin With mTOR Inhibitor–Based Immunosuppression in a Kidney Transplant Recipient With Sickle Cell Disease (2017) (12)
- Cytomegalovirus prophylaxis with valganciclovir in cytomegalovirus‐seropositive kidney‐transplant patients (2008) (12)
- Polyoma BK virus-associated nephropathy in kidney-transplant patients: Effects of leflunomide on T-cell functions and disease outcome. (2009) (12)
- Direct-acting antiviral therapy for hepatitis E virus? (2017) (12)
- Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies in vivo in Severe Kidney Disease: An Open-Label Phase 2a Study (2022) (11)
- Outcome of Liver Transplant Patients With Preformed Donor‐Specific Anti–Human Leukocyte Antigen Antibodies (2020) (11)
- Incidence, predictors and prognosis of genotype 4 hepatitis E related liver failure: A tertiary nested case‐control study (2019) (11)
- Efficacy of immunoadsorption to reduce donor-specific alloantibodies in kidney-transplant candidates. (2015) (11)
- Calcineurin inhibitor‐sparing regimens based on mycophenolic acid after kidney transplantation (2015) (11)
- Enteric-Coated Mycophenolate Sodium A Review of its Use in the Prevention of Renal Transplant Rejection (2008) (11)
- Temporal trends in living kidney donation in France between 2007 and 2017. (2019) (11)
- 12 Weeks of a Ribavirin‐Free Sofosbuvir and Nonstructural Protein 5A Inhibitor Regimen Is Enough to Treat Recurrence of Hepatitis C After Liver Transplantation (2018) (11)
- Simultaneous cutaneous infection due to Paecilomyces lilacinus and Alternaria in a heart transplant patient (2012) (11)
- Impact of the new MELD‐based allocation system on waiting list and post‐transplant survival—a cohort analysis using the French national CRISTAL database (2019) (11)
- Evidence-based practice: Guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patients. (2019) (11)
- Viral infections after kidney transplantation. (2011) (11)
- A 3-month course of ciprofloxacin does not prevent BK virus replication in heavily immunosuppressed kidney-transplant patients. (2016) (11)
- CYP 3 A 5 genotype does not influence everolimus in vitro metabolism and clinical pharmacokinetics in renal transplant recipients (2017) (10)
- Conversion from sirolimus to everolimus in maintenance renal transplant recipients within a calcineurin inhibitor-free regimen: results of a 6-month pilot study. (2008) (10)
- Sarcoidosis-related hypercalcemia in 3 chronic hemodialysis patients. (2006) (10)
- Failure to respond to ribavirin despite elevated intra‐erythrocyte zinc level in transplant‐patients with chronic hepatitis E virus infection (2019) (10)
- Alteration of direct and indirect effects of cytomegalovirus. (2007) (10)
- Predictive model of 1-year postoperative renal function after living donor nephrectomy (2017) (10)
- Kinetics of plasmatic cytokines and cystatin C during and after hemodialysis in septic shock-related acute renal failure (2010) (10)
- Predictive Factors for Anemia Six and Twelve Months After Orthotopic Liver Transplantation (2006) (10)
- Pharmacodynamic effects of everolimus on anti-CD3 antibody-stimulated T-lymphocyte proliferation and interleukin-10 synthesis in stable kidney-transplant patients. (2008) (10)
- Renal function with delayed or immediate cyclosporine microemulsion in combination with enteric‐coated mycophenolate sodium and steroids: results of follow up to 30 months post‐transplant (2007) (10)
- Effector memory CD8 T cell response elicits Hepatitis E Virus genotype 3 pathogenesis in the elderly (2021) (10)
- Histological long‐term outcomes from acute antibody‐mediated rejection following ABO‐compatible liver transplantation (2017) (10)
- An Association between BK Virus Replication in Bone Marrow and Cytopenia in Kidney-Transplant Recipients (2014) (10)
- Pegylation of IFN-α and Antiviral Activity (2006) (10)
- Achievement of Low-Density Lipoprotein Cholesterol Targets in CKD (2019) (10)
- Effect of mycophenolate mofetil monotherapy on T-cell functions and inosine monophosphate dehydrogenase activity in patients undergoing a kidney transplantation. (2006) (10)
- Dosing ribavirin in hepatitis E‐infected solid organ transplant recipients (2018) (10)
- Detection of viral hepatitis E in clinical liver biopsies (2017) (9)
- [Hepatitis E virus: A new entity]. (2010) (9)
- Darbepoetin-alfa in renal-transplant patients: an observational monocentric study. (2008) (9)
- Early post-transplant complications following ABO-incompatible kidney transplantation (2015) (9)
- Is thyroid cancer recurrence risk increased after transplantation? (2012) (9)
- Conversion from everolimus with low-exposure cyclosporine to everolimus with mycophenolate sodium maintenance therapy in kidney transplant recipients: a randomized, open-label multicenter study. (2012) (9)
- A prospective study in male recipients of kidney transplantation reveals divergent patterns for inhibin B and testosterone secretions (2014) (9)
- Hepatitis E Virus: How It Escapes Host Innate Immunity (2020) (9)
- Clinical Utility of Biochemical Markers for the Prediction of COVID-19−Related Mortality in Kidney Transplant Recipients (2021) (9)
- Effect of FTY720 on apoptosis of smooth muscle cells. (2007) (9)
- Management of anastomotic biliary stricture after liver transplantation and impact on survival. (2020) (9)
- Clinical Utility of Biochemical Markers for the Prediction of COVID-19−Related Mortality in Kidney Transplant Recipients (2021) (9)
- Acute Page kidney after a kidney allograft biopsy: successful outcome from observation and medical treatment. (2009) (9)
- Urinary Sodium-to-Potassium Ratio and Blood Pressure in CKD (2020) (8)
- Incidence of anti-HLA donor specific antibodies in liver-transplant patients given mTOR inhibitors without calcineurin inhibitors. (2014) (8)
- [Chronic hepatitis E virus infection]. (2009) (8)
- [Cytomegalovirus effects in solid organ transplantation and the role of antiviral prophylaxis]. (2010) (8)
- Patients' motives for consenting or refusing to participate in a clinical trial in organ transplantation (2013) (8)
- Recurrence of oxalate nephropathy after isolated kidney transplantation for primary hyperoxaluria type 2 (2018) (8)
- Percutaneous transluminal angioplasty alone versus stent placement for the treatment of transplant renal artery stenosis. (2019) (8)
- Robot‐assisted laparoscopic partial nephrectomy with renal artery clamping using an endovascular balloon catheter for an allograft kidney tumor: A new perspective to manage renal vascular control? (2018) (8)
- Long term results of liver transplantation for alpha-1 antitrypsin deficiency. (2020) (8)
- Safety of renal transplantation in patients with bipolar or psychotic disorders: a retrospective study (2018) (8)
- Beneficial Effect of Conversion to Belatacept in Kidney-Transplant Patients with a Low Glomerular-Filtration Rate (2014) (8)
- Syphilis-related hepatitis in a liver transplant patient. (2007) (8)
- Hepatitis C virus viral load after conversion from tacrolimus to cyclosporine in liver transplant patients: a pilot study. (2007) (8)
- Treatment of Chronic Hepatitis C Virus Infection in Dialysis Patients: An Update (2010) (8)
- Safety of sofosbuvir‐based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study (2018) (8)
- Evolution of hepatitis C virus quasispecies in renal transplant patients with de novo glomerulonephritis (2003) (8)
- Primary hyperoxaluria type 2 successfully treated with combined liver‐kidney transplantation after failure of isolated kidney transplantation (2020) (8)
- Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials. (2017) (8)
- Robotic Kidney Transplantation for Morbidly Obese Patients Excluded from Traditional Transplantation (2017) (8)
- Seroprevalence of hepatitis E virus (HEV) in a general adult population in Northern Norway: the Tromsø study (2019) (8)
- Validation of a Capillary Dry Blood Sample MITRA-Based Assay for the Quantitative Determination of Systemic Tacrolimus Concentrations in Transplant Recipients (2020) (8)
- Prospects for improved glomerular filtration rate estimation based on creatinine—results from a transnational multicentre study (2020) (8)
- Use of direct‐acting agents for hepatitis C virus‐positive kidney transplant candidates and kidney transplant recipients (2016) (8)
- [Hepatitis E: from zoonotic transmission to chronic infection in immunosuppressed patients]. (2008) (8)
- Combined use of tacrolimus and sirolimus in de novo renal transplant patients: current data. (2005) (8)
- Eculizumab for Thrombotic Microangiopathy Associated with Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation (2017) (8)
- Vertigo after renal transplantation: a sign of paucisymptomatic cryptococcal meningitis. (2006) (7)
- Comparison of graft and patient survival according to the transplantation centre policy for 1-year screening biopsy among stable kidney recipients: a propensity score-based study. (2018) (7)
- BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANT RECIPIENTS: TWO-YEAR OUTCOMES FROM THE BENEFIT STUDY: 1374 (2010) (7)
- Expression of Exhaustion Markers on CD8+ T-Cell Patterns Predict Outcomes in Septic Patients Admitted to the ICU* (2021) (7)
- Plasma cell neoplasia after kidney transplantation: French cohort series and review of the literature (2017) (7)
- Late isolated ocular toxoplasmosis in a belatacept‐treated kidney transplant patient (2016) (7)
- Pegylation of IFN-alpha and antiviral activity. (2006) (7)
- Follow-up of 28 HCMV seropositive renal-transplant recipients: comparison of clinical, biological and virological parameters in the groups of treated versus untreated infected patients. (2004) (7)
- Direct‐acting antivirals and hepatitis B virus (HBV) reactivation in co‐infected HBV/HCV kidney‐transplant recipients (2018) (7)
- Factors Associated With COVID-19 Vaccine Response in Transplant Recipients: A Systematic Review and Meta-analysis (2022) (7)
- Three-Year Outcomes in Kidney Transplant Patients Randomized to Steroid-Free Immunosuppression or Steroid Withdrawal, with Enteric-Coated Mycophenolate Sodium and Cyclosporine: The Infinity Study (2014) (7)
- Pretransplant urinary proteome analysis does not predict development of chronic kidney disease after liver transplantation (2015) (7)
- Monitoring and managing SARS-CoV-2 evolution in immunocompromised populations (2022) (7)
- Life-threatening infections following rituximab therapy in renal transplant patients with mixed cryoglobulinemia. (2006) (7)
- Calcineurin Inhibitors Downregulate HNF-1&bgr; and May Affect the Outcome of HNF1B Patients After Renal Transplantation (2016) (7)
- Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients. (2021) (7)
- Boceprevir-Based Triple Antiviral Therapy for Chronic Hepatitis C Virus Infection in Kidney-Transplant Candidates (2015) (7)
- Mycophenolic Acid 12-Hour Area Under the Curve in De Novo Liver Transplant Patients Given Mycophenolate Mofetil at Fixed Versus Concentration-Controlled Doses (2009) (7)
- Convenient Biological Assay for Polyethylene Glycol-Interferons in Patients with Hepatitis C (2004) (7)
- Cytokine storm induced by a PD1 inhibitor in a renal transplant patient (2021) (7)
- Prevalence of cryoglobulinemia and autoimmune markers in liver transplant patients. (2008) (7)
- Humoral and Cellular Immune Responses of Solid Organ Transplant Patients on Belatacept to Three Doses of mRNA-Based Anti-SARS-CoV-2 Vaccine (2022) (6)
- RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus dispensable of interferon production (2017) (6)
- Outcomes of kidney transplant recipients admitted to the intensive care unit: a retrospective study of 200 patients (2019) (6)
- Severe cytomegalovirus ureteritis in a renal allograft recipient with negative CMV monitoring. (2005) (6)
- The Effectiveness of Topical Cerium Nitrate-Silver Sulfadiazine Application on Overall Outcome in Patients with Calciphylaxis (2019) (6)
- Performance of creatinine-based equations to estimate glomerular filtration rate in White and Black populations in Europe, Brazil, and Africa. (2022) (6)
- [Laparoscopic live donor nephrectomy: surgical technique and results]. (2006) (6)
- Unusual presentation of cytomegalovirus infection in patients after organ transplant. (2009) (6)
- When Should Ribavirin Be Started to Treat Hepatitis E Virus Infection in Transplant Patients? (2016) (6)
- Kidney transplantation improves the clinical outcomes of Acute Intermittent Porphyria. (2020) (6)
- Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19 (2021) (6)
- Actinomycosis: An infrequent disease in renal transplant recipients? (2018) (6)
- Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin (2019) (6)
- The MHC class I MICA gene is a histocompatibility antigen in kidney transplantation (2022) (6)
- Low‐ versus high‐dose rituximab for antibody‐mediated rejection after kidney transplantation (2013) (6)
- Can we prevent donor-specific antibodies from developing after ABO-incompatible kidney transplantation? (2014) (6)
- How to implement immunoadsorption in a polyvalent dialysis unit: a review. (2014) (6)
- Clinical picture: human babesiosis. (2001) (6)
- Monitoring HCMV infection with quantitative real-time PCR in HCMV-positive orthotopic liver transplant recipients, and predictive factors for treatment of the first episode of HCMV viremia. (2006) (6)
- Cyclosporine-A-based immunosuppression and renal functional reserve in organ-transplant patients. (2004) (6)
- [Hepatitis C infection among patients receiving hemodialysis]. (2003) (6)
- Specific organization for in-hospital belatacept infusion to avoid nosocomial transmission during the SARS-CoV-2 pandemic (2020) (5)
- Systematic kidney biopsies after acute allograft pyelonephritis. (2013) (5)
- Direct‐acting antiviral agent–based regimen for HCV recurrence after combined liver‐kidney transplantation: Results from the ANRS CO23 CUPILT study (2017) (5)
- Tolerability of enteric-coated mycophenolate sodium to 1 year in combination with cyclosporine and corticosteroids in renal transplant recipients. (2006) (5)
- Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: Results of a nationwide study (2021) (5)
- Hepatitis E Virus Infection in Iranian Kidney-Transplant Patients (2011) (5)
- Do kidney histology lesions predict long‐term kidney function after liver transplantation? (2012) (5)
- T cell reconstitution after lymphocyte depletion features a different pattern of inhibitory receptor expression in ABO‐ versus HLA‐incompatible kidney transplant recipients (2019) (5)
- Comparison of the exposure of mycophenolate mofetil and enteric-coated mycophenolate sodium in recipients of kidney-pancreas transplantation. (2014) (5)
- Long-term results of conversion from calcineurin inhibitors to sirolimus in 150 maintenance kidney transplant patients. (2012) (5)
- Performance of a commercial assay for detecting and quantifying HEV RNA in faeces (2018) (5)
- Determining the therapeutic range for ribavirin in transplant recipients with chronic hepatitis E virus infection (2020) (5)
- Outcomes of solid organ transplant recipients with invasive aspergillosis and other mold infections (2020) (5)
- A monocentric observational study of darbepoetin alfa in anemic hepatitis-C-virus transplant patients treated with ribavirin. (2008) (5)
- Bendamustine plus rituximab for indolent B‐cell lymphoma of renal significance (2018) (5)
- Thrombotic microangiopathy in a sirolimus-treated renal transplant patient receiving gemcitabine for lung cancer. (2007) (5)
- Aspects urologiques de l’infection à Polyomavirus (2010) (5)
- P0804 : Efficacy of sofosbuvir-based treatment regimens in HIV/HCV co-infected patients after liver transplantation: The ANRS CO23 CUPILT study (2015) (5)
- Identification of Cause of Posttransplant Cachexia by PCR (2012) (5)
- Hepatitis E: Current Status in India and Other Asian Countries (2019) (5)
- Adaptive lymphocyte profile analysis discriminates mild and severe forms of COVID-19 after solid organ transplantation (2021) (5)
- Long‐term, prolonged‐release tacrolimus‐based immunosuppression in de novo kidney transplant recipients: 5‐year prospective follow‐up of the ADHERE study patients (2019) (5)
- No evidence of occult hepatitis C or E virus infections in liver‐transplant patients with sustained virological response after therapy with direct acting agents (2019) (5)
- Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survival (2022) (5)
- COMPARISON OF INDUCTION THERAPY BASED ON CONTINUOUS VS. DISCONTINUOUS ADMINISTRATION OF ANTI-THYMOCYTE GLOBULINS IN RENAL-TRANSPLANT PATIENTS: EFFICACY AND LONG-TERM SAFETY (2004) (5)
- An unusual cause of acute renal failure in a kidney transplant recipient: salmonella enteritidis post-infectious glomerulonephritis. (2007) (5)
- In vitro mitogen-stimulated T-cell from hepatitis C virus-positive liver transplantation candidates, increases T-cell activation markers and T-cell proliferation. (2008) (5)
- Age-adapted percentiles of measured glomerular filtration in healthy individuals: extrapolation to living kidney donors over 65 years (2021) (5)
- Intrahepatic cytokine profile in renal‐transplant patients infected by hepatitis C virus (2005) (5)
- Maintaining immunosuppressive treatment after early allograft nephrectomy does not reduce the risk of anti‐HLA allosensitization (2015) (5)
- Comparison of induction based on continuous vs discontinuous administration of antithymocyte globulins in renal transplant patients: efficacy and long-term safety. (2004) (5)
- [Pneumocystis jiroveci infection associated with organizing pneumonia in a kidney transplant patient]. (2010) (5)
- Belatacept prophylaxis against organ rejection in adult kidney-transplant recipients (2016) (5)
- Everold: A Multicenter Randomized Study for the Use of Everolimus in “Old-for-Old” Renal Transplantation.: Abstract# 2155 (2014) (5)
- Rationale for using belatacept in combination with sirolimus. (2010) (4)
- Incidence of Donor-Specific Anti-HLA Antibodies in Non-HLA-Sensitized Patients Given Tacrolimus Once or Twice Daily During the First 2 Years After Kidney Transplant. (2019) (4)
- Efficacy and safety of tandem hemodialysis and immunoadsorption to desensitize kidney transplant candidates. (2015) (4)
- Successful pregnancy after ABO‐incompatible kidney transplantation (2016) (4)
- Niclosamide inhibits hepatitis E virus through suppression of NF-kappaB signalling. (2021) (4)
- Hepatitis e virus infection in Iranian kidney-transplant patients. (2011) (4)
- Should 12‐ or 24‐week post‐ribavirin follow‐up be considered to define sustained virological response in transplant patients treated for chronic hepatitis E virus infection? (2019) (4)
- Neisseria-cinerea-induced pulmonary cavitation in a renal transplant patient. (2007) (4)
- Drug exposure and perceived adverse drug events reported by liver-transplant patients. (2009) (4)
- Renal Dysfunction in Liver Transplant Patients Treated with Sofosbuvir Based-Regimen for HCV Recurrence: Results from a Large French Prospective Multicentric ANRS CO23 Cupilt (2016) (4)
- Predictive factors for cytomegalovirus infection after orthotopic liver transplantation using an ultrasensitive polymerase chain reaction assay. (2006) (4)
- Combined Liver-Kidney Transplantation With Preformed Anti–human Leukocyte Antigen Donor-Specific Antibodies (2020) (4)
- Casirivimab-Imdevimab to Prevent SARS-CoV-2 Infections in Solid Organ Transplant Recipients. (2022) (4)
- The Athena Study: 12 Months Safety and Efficacy Data for Everolimus Combined with Tacrolimus or Cyclosporine Compared to a Standard Tacrolimus-Mycophenolate Regimen in de Novo Kidney Transplant Patients (2018) (4)
- Combined Liver-Kidney Transplantation With Preformed Anti–human Leukocyte Antigen Donor-Specific Antibodies (2020) (4)
- Monitoring human cytomegalovirus (HCMV) in HCMV-seropositive orthotopic liver-transplant recipients by means of quantitative real-time polymerase chain reaction. (2006) (4)
- Isolated Aspergillosis Myocardial Abscesses in a Liver-Transplant Patient (2014) (4)
- Combined Liver-Kidney Transplantation With Preformed Anti–human Leukocyte Antigen Donor-Specific Antibodies (2020) (4)
- Omicron breakthrough infection in a kidney‐transplant patient given pre‐exposition casirivimab and imdevimab monoclonal antibodies (2022) (4)
- [Hepatitis E infection in dialysis and after transplantation]. (2010) (4)
- Epithelial to Mesenchymal Transition Markers in Kidney Transplant Recipients: The CERTITEM Trial.: Abstract# 717 (2014) (4)
- Rituximab therapy for cytomegalovirus‐associated auto‐immune hemolytic anemia in a liver‐transplant recipient (2008) (4)
- Kidney transplantation during the COVID‐19 pandemic: Potential long‐term consequences of an early post‐transplant infection (2020) (4)
- Three-dimensional laparoscopy for living-donor nephrectomy with vaginal extraction: The first case (2017) (3)
- The spectrum of kidney function alterations in adolescents with a solitary functioning kidney (2021) (3)
- V47 A new surgical area opened in renal transplantation: A pure robot-assisted approach for both living donor nephrectomy and kidney transplantation using transvaginal route (2016) (3)
- Five‐year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE study (2022) (3)
- Tacrolimus Granules for Oral Suspension as Post-Transplant Immunosuppression in Routine Medical Practice in France: The OPTIMOD Study (2018) (3)
- New Insights into Acute-on-Chronic Kidney Disease in Nephrology Patients: The CKD-REIN Study. (2021) (3)
- Malignancies in hepatitis C virus‐positive and ‐negative kidney transplant recipients: A case‐controlled study (2017) (3)
- Influenza A (H1N1) virus‐induced hepatocellular injury in a kidney transplant patient (2011) (3)
- Epidemiological and clinical study of microsporidiosis in French kidney transplant recipients from 2005 to 2019: TRANS‐SPORE registry (2021) (3)
- Laparoscopy for living donor left nephrectomy: Comparison of three‐dimensional and two‐dimensional vision (2019) (3)
- The Achilles tendon of preventing BK virus nephropathy (2013) (3)
- Rat Hepatitis E Virus: Presence in Humans in South-Western France? (2021) (3)
- Changing of therapeutic trends between the 1st and 2nd wave did not reduce COVID-19 related mortality of renal transplant recipients: a national registry study. (2021) (3)
- Comparison of two strategies based on mammalian target of rapamycin inhibitors in secondary prevention of non‐melanoma skin cancer after kidney transplantation, a pilot study (2020) (3)
- Cryptococcal Meningitis in Kidney Transplant Recipients: A Two-Decade Cohort Study in France (2022) (3)
- FTY720 Inhibits Tumor Necrosis Factor-alpha-Induced Proliferation and Extracellular Signal-Regulated Kinase Phosphorylation of Human Smooth Muscle Cells. (2009) (3)
- Harmful effect of saline infusion in a patient with glycyrrhizic acid poisoning. (2010) (3)
- C5L2 IN RENAL ISCHEMIA-REPERFUSION INJURY (2016) (3)
- Living-donor kidney transplantation: comparison of sequential and simultaneous surgical organizations (2020) (3)
- [161] HEPATITIS E VIRUS INFECTION CAN EVOLVE TO CHRONIC HEPATITIS IN ORGAN-TRANSPLANT PATIENTS (2007) (3)
- Response to the KDOQI US Commentary on the 2018 KDIGO Hepatitis C Guideline. (2020) (3)
- SAT-208-Zinc/Ribavirin: A possible treatment option in chronically HEV genotype 3 infected patients without SVR under ribavirin monotherapy (2019) (3)
- Urgent-start dialysis in patients referred early to a nephrologist-the CKD-REIN prospective cohort study. (2021) (3)
- Microsporidiosis after liver transplantation: A French nationwide retrospective study (2021) (3)
- Anti‐IL‐2R blockers comparing with polyclonal antibodies: Higher risk of rejection without negative mid‐term outcomes after ABO‐incompatible kidney transplantation (2019) (3)
- Non-tolerability of double-filtration plasmapheresis in antibody-incompatible kidney transplant candidates. (2015) (3)
- Pharmacokinetics and Pharmacodynamics of Once-daily Prolonged-release Tacrolimus in Liver Transplant Recipients. (2019) (3)
- [Hepatitis E virus]. (2015) (3)
- [Hepatitis C virus infection in renal-transplant patients]. (2004) (2)
- New Insights on CMV Management in Solid Organ Transplant Patients: Prevention, Treatment, and Management of Resistant/Refractory Disease (2022) (2)
- Fatal encephalitis and Borna Disease Virus‐1 seropositivity in two kidney‐transplant patients living in the same nonendemic area (2021) (2)
- CONVERSION FROM CYCLOSPORINE TO EVEROLIMUS LEADS TO BETTER RENAL FUNCTION AND TO PROFOUND CHANGES IN EVEROLIMUS AND MYCOPHENOLATE METABOLISM (2006) (2)
- No evidence of genotype-3 hepatitis E virus-induced myocarditis. (2016) (2)
- A Randomized Prospective Study Comparing Anti–T-Lymphocyte Igs to Basiliximab in Highly Sensitized Kidney Transplant Patients (2020) (2)
- Low serum neutralization of Omicron variants a month after AZD7442 prophylaxis initiation (2022) (2)
- Impact of calcineurin inhibitor‐free immunosuppression on de novo donor‐specific antibody formation in liver transplant recipients (2022) (2)
- Is a single low-fixed dose of rituximab sufficient for treating acute humoral rejection after kidney transplantation? (2009) (2)
- Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence: Prophylaxis makes the difference. (2019) (2)
- External Validation of a Predictive Model to Estimate Renal Function After Living Donor Nephrectomy (2021) (2)
- Identifying the Specific Causes of Kidney Allograft Loss (2018) (2)
- [Hepatitis E: an emerging disease]. (2012) (2)
- Exploring the Viability of Kidneys Discarded in the US: A Comparison of Kidney Utilization Patterns and Outcomes in the US and France (2018) (2)
- Cytomegalovirus Management in Solid Organ Transplant Recipients: A Pre-COVID-19 Survey From the Working Group of the European Society for Organ Transplantation (2022) (2)
- FO051THE IMPACT OF GFR EVALUATION TECHNIQUE ON LIVING KIDNEY DONATION ELIGIBILITY (2018) (2)
- [Urologic aspects of Polyomavirus infection]. (2010) (2)
- Living kidney donor evaluation for all candidates with normal estimated GFR for age (2021) (2)
- Predictive Factors, Natural History and Outcome of Chronic Hepatitis E Virus Infection in Solid-Organ-Transplant Patients: A Retrospective Multicenter Study (2011) (2)
- Everolimus‐induced recurrent pericardial effusion after kidney transplantation (2013) (2)
- Impact of mycophenolic acid dose modifications on renal function after kidney transplantation. (2006) (2)
- Belatacept as maintenance therapy in kidney transplant recipients with ANCA-associated vasculitis. (2021) (2)
- Each Additional Hour of Cold Ischemia Time Significantly Increases the Risk of Graft Failure and Mortality After Renal Transplantation.: Abstract# C1832 (2014) (2)
- [Syphilis hepatitis and liver transplantation]. (2007) (2)
- Should we keep using Ribavirin to Treat Hepatitis C Recurrence after Liver Transplantation? Results from the CO23 ANRS Cupilt Study (2016) (2)
- Impact of Casirivimab-Imdevimab on Severe Acute Respiratory Syndrome Coronavirus 2 Delta Variant Nasopharyngeal Virus Load and Spike Quasispecies (2022) (2)
- Should Persistent Hepatitis E Virus Replication in Transplant Patients Be Tolerated? (2017) (2)
- PREDICTIVE FACTORS OF POST-RENAL TRANSPLANT ANEMIA (2004) (2)
- Hepatitis E Infections in Transplants (2020) (2)
- Impact of transplant accessibility for sensitized patients by avoiding unacceptable antigens (2017) (2)
- T-cell function in maintenance renal transplant patients receiving mycophenolate mofetil and steroids with or without tacrolimus. (2008) (2)
- [Monitoring of calcineurin inhibitors induced-nephrotoxicity]. (2008) (2)
- Cardiac impact of arteriovenous fistulas: what tools to assess? (2020) (2)
- Conversion From Belatacept to Another Immunosuppressive Regimen in Maintenance Kidney-Transplantation Patients (2020) (2)
- Hepatitis E Virus Quasispecies in Cerebrospinal Fluid with Neurological Manifestations (2021) (2)
- Performance of two commercial assays for detecting HEV (2013) (2)
- A MULTIDIMENSIONAL PROGNOSTIC SCORE AND NOMOGRAM TO PREDICT KIDNEY TRANSPLANT SURVIVAL: THE INTEGRATIVE BOX (IBOX) SYSTEM (2017) (2)
- Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021 (2022) (2)
- 1229 COMPARISON OF VIROLOGICAL RESPONSE BETWEEN RIBAVIRIN AND PEG-INTERFERON MONOTHERAPY DURING AUTOCHTONOUS CHRONIC HEPATITIS E VIRUS INFECTION (2013) (2)
- The FcγRIIIA‐158 VV genotype increased the risk of post‐transplant lymphoproliferative disorder in T‐cell‐depleted kidney transplant recipients – a retrospective study (2020) (2)
- Do natural antibodies have a detrimental effect after kidney transplantation? (2018) (2)
- [Kidney failure after liver transplantation]. (2021) (2)
- Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in de novo Kidney Transplant Patients Across Europe (2022) (2)
- Therapeutic education as a tool to improve patient‐reported and clinical outcomes after renal transplantation: results of the EPHEGREN multicenter retrospective cohort study (2021) (2)
- Cumulative radiation dose from medical imaging in kidney transplant patients (2012) (2)
- Unmet Needs for the Treatment of Chronic Hepatitis E Virus Infection in Immunocompromised Patients (2022) (1)
- [Efficiency of rituximab treatment for recurrence of membranous glomerulopathy after renal transplantation]. (2007) (1)
- Prophylaxis of bacterial infections in cirrhosis: Is an optimal 25-OH vitamin D level required? (2014) (1)
- New evidence shows it is time to stop unnecessary use of antibiotics in kidney transplant recipients with asymptomatic bacteriuria. (2020) (1)
- [Kidney nephrectomy after allograft failure]. (2013) (1)
- BK Polyomavirus. (2022) (1)
- Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. (2022) (1)
- Outcomes on Allograft Function after 12 Months with Everolimus Plus either Tacrolimus or Cyclosporine Compared to a Standard Tacrolimus-MPA Regimen in De Novo Renal Transplant Recipients: The Athena Study (2018) (1)
- Hepatitis E virus infection and acute non-traumatic neurological injury: an international prospective pilot study (2017) (1)
- Phototherapy for neonatal jaundice (1977) (1)
- Magnetic Black-Star® double J stent in kidney transplantation: Is it worthy? (2019) (1)
- Predictive factors for anemia within the first year after orthotopic liver transplantation. (2006) (1)
- Impaired antigen-specific B-cell responses after Influenza vaccination in kidney transplant recipients receiving co-stimulation blockade with Belatacept (2022) (1)
- Early necrotic skin lesions after a ABO‐incompatible kidney transplantation: The threat of Cunninghamella Spp. (2019) (1)
- What are the Management Issues for Hepatitis C in Dialysis Patients? (2014) (1)
- Possible patient to patient transmission of progressive multifocal leukoencephalopathy among kidney-transplant patients (2020) (1)
- Three-dimensional laparoscopy for living-donor nephrectomy. (2017) (1)
- Transplantation rénale robotique « sans incision » : insertion du rein par voie vaginale avec reconstruction vaginale endocorporelle (2015) (1)
- Machine learning does not outperform traditional statistical modelling for kidney allograft failure prediction. (2022) (1)
- Reply to Coussement et al. (2021) (1)
- [Is there a place for ribavirin in the treatment for renal transplant patients infected by hepatitis C virus?]. (2003) (1)
- Benign Prostatic Hyperplasia Endoscopic Surgical Procedures in Kidney Transplant Recipients: A Comparison Between Holmium Laser Enucleation of the Prostate, GreenLight Photoselective Vaporization of the Prostate, and Transurethral Resection of the Prostate (2019) (1)
- Long-term outcomes after ABO-incompatible kidney transplantation; a single-center French study (2017) (1)
- Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations - twice daily (2010) (1)
- EVOLUTION OF THE HYPERVARIABLE REGION-1 OF HEPATITIS C VIRUS AND LIVER FIBROSIS PROGRESSION IN RENAL-TRANSPLANT RECIPIENTS (2004) (1)
- P1757RITUXIMAB FOR RECURRENCE OF PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS AFTER KIDNEY TRANSPLANTATION: RESULTS OF A NATIONWIDE STUDY (2020) (1)
- Incidence of cytomegalovirus infection in seropositive kidney transplant recipients treated with everolimus: A randomized, open‐label, multicenter phase 4 trial (2022) (1)
- Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): a pragmatic, multicentre, randomized, controlled trial in Renal Clinical Microbiology and Infection (2020) (1)
- O109 : Treatment of severe HCV-recurrence after liver transplantation using sofosbuvir-based regimens: The ANRS CO23 CUPILT study (2015) (1)
- [Epidemiological description of patients with neurological conditions in kidney transplant recipients]. (2010) (1)
- Outcomes with Tacrolimus-Based Immunosuppression After Kidney Transplantation from Standard- and Extended-Criteria Donors – A Post Hoc Analysis of the Prospective OSAKA Study (2020) (1)
- Significant Anti-CMV/BKV Effect of a Modern Everolimus-Based Regimen Comparted to Standard Tacrolimus-MPA Regimen in de Novo Kidney Transplant Recipients: Athena 12 months Data on Infections (2018) (1)
- Absence of Mortality Differences Between the First and Second COVID-19 Waves in Kidney Transplant Recipients (2022) (1)
- Sofosbuvir-Based-Regimen for HCV Recurrence after Combined Liver-Kidney Transplantation : Results from the ANRS CO23 Cupilt Study (2016) (1)
- Human Babesiosis (2001) (1)
- Influence des immunosuppresseurs co-administrés au mycophénolate mofétil lors du dosage de l’acide mycophénolique par technique immuno-enzymatique (2011) (1)
- MO385: Performance of Creatinine-Based Equations to Estimate Glomerular Filtration Rate in White and Black Subjects From Europe, Brazil and Africa (2022) (1)
- Occult Hepatitis C Virus Infection: Where are We Now? (2011) (1)
- Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation (2021) (1)
- An unexpected diagnosis in a renal-transplant patient with proteinuria treated with everolimus: AL amyloidosis. (2014) (1)
- Benign prostatic hyperplasia endoscopic surgical procedures in kidney transplant recipients: a comparison between HoLEP, GreenLight photoselective vaporization of the prostate and TURP. (2019) (1)
- Hemodynamic and Metabolic Tolerance of Acetate-Free Biofiltration in Mechanically Ventilated Critically Ill Patients: A Real-Life Study (2021) (1)
- [QuiPO: who inject EPO?]. (2013) (1)
- ABO-Incompatible Robotic-Assisted Kidney Transplantation in the Obese Recipient (2020) (1)
- Renal function outcomes with prolonged-release tacrolimus QD after De Novo liver transplantation for different primary diseases: Ad Hoc analysis from the DIAMOND randomized, controlled trial (2014) (1)
- [Prevalence and incidence of hepatitis C virus in hemodialysis: diagnosis and prevention]. (2008) (1)
- BREAKTHROUGH IN THE MANAGEMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME AFTER KIDNEY TRANSPLANTATION: A NATIONWIDE STUDY (2017) (1)
- An automated histological classification system for precision diagnostics of kidney allografts. (2023) (1)
- The Impact of Acute Rejection on Renal Function - Perspectives from the OSAKA Study: 1101 (2012) (1)
- Renal function and histology in kidney transplant patients receiving tacrolimus and sirolimus or mycophenolate mofetil. (2006) (1)
- [Long-term outcome of patients with renal transplant and neural tube defect]. (2010) (1)
- Spectrum of Kidney Disorders Associated with T-Cell Immunoclones (2022) (1)
- Thymoma and solid-organ transplantation. (2012) (1)
- Hepatitis C virus infection in nephrology patients (2011) (0)
- Hepatitis E Viruses (2020) (0)
- The oxygen carrier M101 alleviates complement activation, which may be beneficial for donor organ preservation (2022) (0)
- Teaching point Implementation of Immunoadsorption in a Nephrology Unit : The Toulouse Experience (2014) (0)
- Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients. (2023) (0)
- Apolipoprotein-A-I for severe COVID-19-induced hyperinflammatory states: A prospective case study (2022) (0)
- HEPATITIS C VIRUS INFECTION IN NEPHROLOGY PATIENTS ÃÅÏÀÒÈÒ Ñ-ÂÈÐÓÑÍÀß ÈÍÔÅÊÖÈß Ó ÍÅÔÐÎËÎÃÈ×ÅÑÊÈÕ ÏÀÖÈÅÍÒΠ(2013) (0)
- Subclinical rejection-free diagnostic after kidney transplantation using blood gene expression. (2023) (0)
- [Hepatitis E virus infection]. (2018) (0)
- The authors reply. (2018) (0)
- 80 Laparoscopic living donor nephrectomy: Predictors of warm ischemia time and consequences for the transplant (2016) (0)
- Infection After Rituximab Therapy in Kidney‐Transplant Patients (2010) (0)
- Selection of Appropriate Composite Endpoints Is Critical for Assessing Efficacy Failure - Perspectives from the OSAKA Study: 1102 (2012) (0)
- Disease recurrence after liver transplantation for NAFLD cirrhosis is ineluctable (2023) (0)
- CYP 3 A 5 genotype does not influence everolimus metabolism and in vitro clinical pharmacokinetics in renal transplant recipients (2012) (0)
- 43-OR: Antibodies towards HLA class I antigens provoke graft arteriosclerosis (2007) (0)
- Safety and Effectiveness of Percutaneous Renal Artery Embolization for Volume Reduction of Enlarged Polycystic Kidneys Before Transplantation. Results at 3 Months.: Abstract# D2533 (2014) (0)
- Long‐term outcome of liver transplantation for autoimmune hepatitis: A French nationwide study over 30 years (2023) (0)
- Long-term outcomes after ABO-incompatible kidney transplantation (2017) (0)
- [Therapeutic education in the transplant patient's pathway]. (2016) (0)
- Effects of intraoperative versus postoperative administration of rabbit antithymocyte antibodies on 1-year renal function in renal transplant patients. (2006) (0)
- P79 Hepatitis E virus is highly endemic in South West France (2010) (0)
- , Lionel Sebastien Lhomme , Florence Abravanel , Martine Dubois , Immunocompromised Patients of the Hepatitis E Virus in Characterization of the Polyproline Region (2014) (0)
- SP835MORTALITY IN PATIENTS WITH A FAILED TRANSPLANT AFTER A RETURN TO DIALYSIS (2015) (0)
- Albuminuria and masked uncontrolled hypertension in chronic kidney disease (2017) (0)
- Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort (2019) (0)
- Renal transplantation - clinical studies - 1 (2009) (0)
- Acetate-Free Biofiltration Versus Online Acetate-Free Hemodiafiltration in Patients at High Risk of Hemodialysis Intolerance (2022) (0)
- Short Presentations on Posters (2018) (0)
- Hepatitis-Associated Glomerulonephritis (2019) (0)
- SP830EARLY RECURRENCE OF ISOLATED RENAL MICROPOLYANGIITIS DURING THE FIRST THREE MONTHS OF KIDNEY TRANSPLANTATION (2015) (0)
- P0488 : Dissecting the complexity of interferon response that cross talks with 4E-BP1 in hepatitis E virus infection (2015) (0)
- P188: Hepatitis E IgG seroprevalence in three hyperendemic areas: Nepal, Bangladesh and southwest France (2015) (0)
- CNI Free Immunosuppression in Heart Transplant Patients Treated With Everolimus: Results of a Multicenter French Registry (2014) (0)
- Unusual Pathology in a Kidney from a Heart-Transplant Patient (2017) (0)
- Correction to: Seroprevalence of hepatitis E virus (HEV) in a general adult population in Northern Norway: the Tromsø study (2019) (0)
- GLOBAL, MULTICENTER, NONINTERVENTIONAL STUDY TO ASSESS LONG-TERM OUTCOMES IN KIDNEY TRANSPLANT RECIPIENTS CONVERTING FROM TWICE-DAILY, IMMEDIATE-RELEASE TACROLIMUS TO ONCE-DAILY, PROLONGED-RELEASE TACROLIMUS: 4-YEAR INTERIM ANALYSIS OF THE CHORUS STUDY (2020) (0)
- Therapeutic window for ribavirin therapy in transplant recipients with chronic hepatitis E virus infection (2020) (0)
- [Hepatitis E virus replication in intestinal cells: A new facet of this virus revealed]. (2021) (0)
- Diagnostic and management strategies for chronic hepatitis E infection (2023) (0)
- Feasibility and perioperative outcomes of robot-assisted renal transplantation: An initial experience (2017) (0)
- FC055 PERCENTILES OF NORMAL MEASURED GLOMERULAR FILTRATION RATE BASED ON DATA FROM LIVING KIDNEY DONORS (2021) (0)
- MP52-14 ROBOT-ASSISTED KIDNEY TRANSPLANTATION IN THE OBESE: UPDATE OF A MONOCENTRIC STUDY WITH 28 PATIENTS (2020) (0)
- Low to undetectable Omicron BQ.1.1 neutralization by patient’s sera a month after initiation of AZD7442 600mg (2023) (0)
- 564 TREATMENT OF AUTOCHTHONOUS ACUTE HEPATITIS E IN IMMUNOCOMPETENT PATIENTS WITH SHORT TERM RIBAVIRIN: A MULTICENTRIC FRENCH EXPERIENCE (2012) (0)
- Long-term results of a calcineurin inhibitor-free immunosuppression based on Thymoglobulin® and mycophenolate mofetil in elderly kidney transplant recipients (2008) (0)
- An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in denovo kidney transplant patients (0)
- ResearchKinetics of plasmatic cytokines and cystatin C during and after hemodialysis in septic shock-related acute renal failure (2015) (0)
- Autoantibodies against granulocyte macrophage colony‐stimulating factor and Nocardia infection in solid organ transplant recipients (2020) (0)
- Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19 (2021) (0)
- [Domino transplantation of a living-donor kidney graft affected by thrombotic microangiopathy: surgical aspects]. (2009) (0)
- 465 LONG TERM RESULTS OF LIVER TRANSPLANTATION FOR WILSON'S DISEASE (WD): THE FRENCH EXPERIENCE (2010) (0)
- [Association of Takayasu's arteritis and hemorrhagic rectocolitis]. (2000) (0)
- Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations - twice daily Prograf( R (cid:13) ) and once daily Advagraf( R (cid:13) ). (2017) (0)
- Anti-CD38 Monoclonal Antibodies Interfere With Isoagglutinin Detection. (2023) (0)
- [Hepatitis C virus and renal transplantation]. (2004) (0)
- Reply to: "Association of hepatitis E virus infection and myasthenia gravis: A pilot study". (2018) (0)
- Nonskeletal and skeletal effects of high doses versus low doses of vitamin D3 in renal transplant recipients: Results of the VITALE (VITamin D supplementation in renAL transplant recipients) study, a randomized clinical trial. (2023) (0)
- EFFICACY AND SAFETY OF INDUCTION THERAPY WITH ANTITHYMOCYTE GLOBULINS (ATG) IN HEPATITIS C VIRUS (HCV) POSITIVE LIVER TRANSPLANT PATIENTS : COMPARISON WITH ANTI-CD25 INDUCTION THERAPY (2004) (0)
- Characterisation of the Specificity, Functionality and Durability of Host T-Cell Responses against the Full HEV Genome (2016) (0)
- Humoral and Cellular Responses to a Delayed Fourth SARS-CoV-2 mRNA-Based Vaccine in Weak Responders to 3 Doses Kidney Transplant Recipients (2022) (0)
- Chronic hepatitis E virus infection: is it reality or hype and where does it matter? (2020) (0)
- LONG-TERM EVOLUTION OF LYMPHOCYTES SUBSETS AFTER INDUCTION THERAPY BASED ON CONTINUOUS VS. DISCONTINUOUS ADMINISTRATION OF ANTI-THYMOCYTE GLOBULINS IN RENAL-TRANSPLANT PATIENTS (2004) (0)
- CLINICAL—LIVER, PANCREAS, AND BILIARY TRACT Ribavirin Therapy Inhibits Viral Replication on Patients With Chronic Hepatitis E Virus Infection (2010) (0)
- The CD226/TIGIT axis is involved in T cell hypo-responsiveness appearance in long-term kidney transplant recipients (2022) (0)
- Donor Specific Anti-HLA Antibodies Towards HLA Cw and HLA DP Should Be Considered as Pathogenic in Kidney Transplantation.: Abstract# B852 (2014) (0)
- Transplantation - clinical II (2012) (0)
- Heparin-free regional anticoagulation of haemodialysis filters with calcium-free dialysate: is citrate mandatory? (2021) (0)
- A Phase 3 Active-Controlled Study of Maribavir (MBV) for the Treatment (Tx) of Transplant Recipients with Refractory/Resistant (RR) Cytomegalovirus (CMV): Study Design (2020) (0)
- MP76-12 ROBOT-ASSISTED KIDNEY TRANSPLANTATION IN THE OBESE: RESULT AT 2 YEARS OF THE FIRST FRENCH SERIES (2019) (0)
- Baseline 18F-FDG Metabolic Tumor Volume Predicts Response to Rituximab Induction in Post-transplant Lymphoproliferative Disorders: A Multi-institutional Retrospective Study (2023) (0)
- Disclosure List (2021) (0)
- Sirolimus in Severe Hyperinsulinemic Hypoglycemia (2014) (0)
- FC 126IMPACT OF POLYCLONAL ANTI-T-LYMPHOCYTE IMMUNOGLOBULINS ON THE RECURRENCE OF IGA NEPHROPATHY AFTER KIDNEY TRANSPLANTATION: THE PIRAT STUDY (2021) (0)
- Correction to: Seroprevalence of hepatitis E virus (HEV) in a general adult population in Northern Norway: the Tromsø study (2019) (0)
- Impact of menopausal status on kidney adaptation after unilateral nephrectomy for kidney donation in women (2021) (0)
- IS THIRD RENAL TRANSPLANTATION WORKING, IS IT SAFE? (2008) (0)
- Risk of death following kidney allograft failure: a systematic review and meta-analysis of cohort studies (2014) (0)
- [Monster cells in a bronchoalveolar lavage fluid]. (2007) (0)
- Can the COVID-19 Pandemic Improve the Management of Solid Organ Transplant Recipients? (2022) (0)
- Hepatitis E virus: from the infected organism to the cellular response. (2018) (0)
- Long-term outcome of reusing a kidney allograft retrieved from a living recipient and retransplanted into a second recipient. (2013) (0)
- Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis (2023) (0)
- Liver transplantation for autoimmune hepatitis: Pre‐transplant does not predict the early post‐transplant outcome (2022) (0)
- Physiopathologie de l'infection virale C en transplantation rénale (2006) (0)
- [Prevention and treatment of viral hepatitis]. (1984) (0)
- Infection par le virus de l ’ hépatite C en hémodialyse (2003) (0)
- Simplified method of regional citrate anticoagulation for continuous extra renal epuration (2002) (0)
- Performance, limitations and utility of cystatin C as an endogenous GFR marker in renal transplantation (2012) (0)
- P186: Serology based retrospective study of viral hepatitis in A tertiary care hospital (2015) (0)
- [Not Available]. (2015) (0)
- Recurrence of primary sclerosing cholangitis after liver transplantation: a french cohort study including 571 patients (2022) (0)
- 129 PREDICTIVE FACTORS, NATURAL HISTORY AND OUTCOME OF CHRONIC HEPATITIS E VIRUS INFECTION IN SOLID-ORGAN-TRANSPLANT PATIENTS: A RETROSPECTIVE MULTICENTER STUDY (2011) (0)
- Dosing of Enteric-Coated Mycophenolate Sodium Under Routine Conditions: An Observational, Multicenter Study in Kidney Transplantation. (2016) (0)
- [Not Available]. (2015) (0)
- Acute antibody mediated rejection following sleeve gastrectomy in a kidney-transplant recipient treated with a belatacept-Mycophenolate mofetil based therapy. (2017) (0)
- Management and Outcome After Early Renal Transplant Vein Thrombosis: A French Multicentre Observational Study of Real-Life Practice Over 24 Years (2023) (0)
- - 1-CYP 3 A 5 genotype does not influence everolimus in vitro metabolism and clinical pharmacokinetics in renal transplant recipients (2010) (0)
- Sofosbuvir and NS5A inhibitors without Ribavirin during 12 weeks are efficient to treat hepatitis C recurrence after liver transplantation only in genotype 1. Results from the CO23 ANRS CUPILT study. (2016) (0)
- Tacrolimus QD Is Equivalent to Tacrolimus BID in All Measures of Clinical Efficacy: 1668 (2012) (0)
- Evaluation of the efficacy of HEMO2life®, a marine OXYgen carrier for Organ Preservation (OxyOp2) in renal transplantation: study protocol for a multicenter randomized trial (2023) (0)
- Dynamic prediction of renal survival using artificial intelligence: an international study of deeply phenotyped cohorts of kidney transplant recipients (2020) (0)
- Blood epuration of middle molecules in continuous venovenous hemodiafiltration with regional citrate anticoagulation versus systemic heparinization (2009) (0)
- Impact of targeted hypothermia in expanded-criteria organ donors on recipient kidney-graft function: study protocol for a multicentre randomised controlled trial (HYPOREME) (2022) (0)
- Consequences of oral antithrombotic use in patients with chronic kidney disease (2021) (0)
- patients with advanced liver cirrhosis Nitric oxide and carbon monoxide lung transfer in (2015) (0)
- Specificities of Meningitis and Meningo-Encephalitis After Kidney Transplantation: A French Retrospective Cohort Study (2023) (0)
- Hepatitis E: The Commonest Viral Zoonosis Worldwide? (2015) (0)
- IN REPLY TO'EVIDENCE OF OCCULT HEPATITIS C VIRUS INFECTION IN HEMODIALYSIS PATIENTS' (2009) (0)
- [Treatment of hepatitis E virus infection]. (2015) (0)
- [The evolution of the hypervariable region-1 of hepatitis C virus may predict liver fibrosis outcome after renal transplantation]. (2005) (0)
- Weekly high‐dose liposomal amphotericin B prevents invasive aspergillosis after heart transplantation (2021) (0)
- Progression of histological lesions after ABO incompatible kidney transplantation (2022) (0)
- [167] LONG TERM EFFICACY OF ENDOSCOPIC TREATMENT OF BILIARY COMPLICATIONS (BC) AFTER ORTHOTOPIC LIVER TRANSPLANTATION (OLT) (2007) (0)
- [Not Available]. (2015) (0)
- Effectiveness and Tolerance of Renin-Angiotensin System Inhibitors With Aging in Chronic Kidney Disease (2021) (0)
- P187: Co‐ circulation of hepatitis A, B and C with hepatitis E virus genotype 1a during major outbreak of 2014 in Nepal (2015) (0)
- FC 107: Development and Validation of a Machine Learning-Based Virtual Biopsy System in Kidney Transplant Patients (2022) (0)
- Management of Hepatitis A and E Virus Infection (2021) (0)
- ASSESSMENT OF T CELL FUNCTION AND T CELL ACTIVATION IN HEALTHY VOLUNTEERS, DIALYSIS AND RENAL-TRANSPLANT PATIENTS BY USING A WHOLE BLOOD FACS ASSAY. (2006) (0)
- University of Birmingham Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients (2017) (0)
- FERTILITY IN MEN WITH CHRONIC RENAL FAILURE BEFORE AND AFTER KIDNEY TRANSPLANTATION (2008) (0)
- Transplantation / Clinical studies (2011) (0)
- Alefacept Treatment in the Setting of Transplantation (2014) (0)
- Hepatitis E Virus Infects Neurons and Nervous System (2016) (0)
- [Autochthonous hepatitis E: a new entity]. (2009) (0)
- The MKTS: An Early Prognostic Score of Mortality After Kidney Transplantation.: Abstract# D2481 (2014) (0)
- FP742 THE IMPACT OF AGE ON ACCEPTABLE MEASURED GFR FOR LIVING KIDNEY DONATION (2018) (0)
- Risk factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant recipients: a multinational case-control study. (2022) (0)
- [Living-donor robotic-assisted kidney transplantation: French academic center experience]. (2021) (0)
- Acute Humoral Rejection in the Absence of Anti-HLA Antibodies, a French Nation-Wide Study.: Abstract# B858 (2014) (0)
- Seroprevalence of hepatitis E virus (HEV) in a general adult population in Northern Norway: the Tromsø study (2019) (0)
- Natural History and Determinants of Infectious Complications after Kidney Transplantation: A Nationwide Prospective Population Based Cohort (2018) (0)
- FC 055PERCENTILES OF NORMAL MEASURED GLOMERULAR FILTRATION RATE BASED ON DATA FROM LIVING KIDNEY DONORS (2021) (0)
- COUNTRY-DEPENDENT OUTCOME DIFFERENCES AFTER KIDNEY TRANSPLANTATION IN FRANCE VS. GERMANY – AN ADDITIONAL ANALYSIS OF THE ATHENA STUDY (2020) (0)
- Cryoglobulinemia in HCV-Positive Renal Transplant and Liver Transplant Patients (2012) (0)
- Observational Study of a Large Cohort of Liver and Kidney Transplanted Patients Converted to Tacrolimus QD (ADVAGRAF®): Acceptance and Compliance to ADVAGRAF®.: Abstract# B1185 (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Nassim Kamar?
Nassim Kamar is affiliated with the following schools:
